LFCR: Lifecore Biomedical Inc. Forecast Levels Chart

Corporate company logo of Lifecore (LFCR)

Lifecore Biomedical (LFCR) specializes in the production of complex pharmaceutical components, including hyaluronic acid, leveraging long-term contracts. In Minnesota, Lifecore Biomedical (LFCR) operates sterile filling lines with redundant systems, ensuring process continuity. The current metric stands at 6.31. The price action reflects the resilience of a business that operates in an autonomous cycle, remaining a defensive asset regardless of global economic fluctuations.

LFCR Lifecore Biomedical Inc.: Price Target Chart in the range 04/28/2023 - 11/11/2026

Analytical breakdowns for Lifecore Biomedical (LFCR)

- current price and projected stock value:
Price Chart lifecore.com|LFCR - Analyst Consensus Forecast
- market capitalization information:
Market Valuation Lifecore|LFCR - Enterprise Value
- balance sheet net asset value indicators:
Accounting Value per Share Lifecore Biomedical|LFCR - Company Book Value|Market Value to Book Value lifecore.com|LFCR - Aggregate Company Assets
- debt obligations and liquidity statistics:
Aggregate Debt to Equity Lifecore Biomedical|LFCR - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital lifecore.com|LFCR - Company Aggregate Debts|Debts to Book Capitalization Lifecore|LFCR - Company Long-Term Debt|Company Short-Term Loans and Borrowings Lifecore Biomedical|Quick Liquidity Indicator lifecore.com
- business earnings and investment ratios data:
LFCR - Net Profit|Projected Future Earnings Lifecore Biomedical|LFCR - Price to Earnings Ratio|Future Price to Earnings Multiple lifecore.com|LFCR - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Lifecore|LFCR - Operating profit EBITDA|Net earnings per one share for the last twelve months Lifecore Biomedical|LFCR - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months lifecore.com|LFCR - Net earnings per share growth this year|Projected earnings per share increase next year Lifecore Biomedical
General company analysis:LFCR Lifecore Biomedical Inc.
Flagship merchandise of Lifecore Biomedical, Inc.

Lifecore Biomedical's status as a critical link in the production of injectables for pharmaceutical behemoths directly influences market expectations regarding the business's capitalization. The trend in the analysts' consensus price target reflects an aggregated assessment of the asset's fair value, allowing investors to filter out speculative noise and determine the true trajectory of the company's revaluation through the lens of collective professional expert opinion.

Competitors of Lifecore Biomedical

Price Target Chart IQV (iqvia.com)|Analyst Consensus Forecast LH (Labcorp)|MEDP (Medpace Holdings) - Forecast Levels Chart|ICON Public Limited Company - Analyst Consensus Forecast|Charles River Corp (CRL) - Consensus Target|Evotec SE (EVO) - Price Target Chart|fortrea.com - Fair Value Consensus|Price Target Chart OmniAb|Inotiv Inc - Forecast Levels Chart|Analyst Consensus Forecast CDMO|CTLT (Catalent, Inc) - Fair Value Consensus|Analyst Consensus Forecast SCPX (Scorpius Holdings, Inc.)